Hypoxia and HIF-1α in chondrogenesis

Annals of the New York Academy of Sciences

Volumn 1068, Issue 1, 2006, Pages 66-73

  Schipani, Ernestina ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chondrocytes; HIF 1 ; Hypoxia; VEGF; VHL

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HIF1A PROTEIN, HUMAN; VON HIPPEL LINDAU PROTEIN;

BLOOD VESSEL; BONE DEVELOPMENT; BONE MINERAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CONFERENCE PAPER; ENCHONDRAL OSSIFICATION; FETUS DEVELOPMENT; HYPOXIA; NONHUMAN; PROTEIN DEGRADATION; ANIMAL; CELL DIVISION; CELL HYPOXIA; CYTOLOGY; GENETICS; GROWTH PLATE; HUMAN; MOUSE; MOUSE MUTANT; PHYSIOLOGY; REVIEW;

ANIMALS; CELL DIVISION; CELL HYPOXIA; CHONDROGENESIS; GROWTH PLATE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, KNOCKOUT; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 33744764250     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1346.009     Document Type: Conference Paper

References (46)

1. Giaccia, A., M. Simon & R. Johnson. 2004. The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease. Genes Dev. 18 : 2183 2194.
2. Chen, E., M. Fujinaga & A. Giaccia. 1999. Hypoxic microenvironment within an embryo induces apoptosis and is essential for proper morphological development. Teratology 60 : 215 225.
3. Karsenty, G. 2003. The complexities of skeletal biology. Nature 423 : 316 318.
4. Erlebacher, A. et al. 1995. Toward a molecular understanding of skeletal development. Cell 80 : 371 378.
5. Kronenberg, H. 2003. Developmental regulation of the growth plate. Nature 423 : 332 336.
6. Schipani, E. & S. Provot. 2003. PTHrP, PTH, and the PTH/PTHrP receptor in endochondral bone development. Birth Defects Res. Part C Embryo Today 69 : 352 362.
7. Vu, T. et al. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93 : 411 422.
8. Zelzer, E. et al. 2002. Skeletal defects in VEGF120/120 mice reveal multiple roles for VEGF in skeletogenesis. Development 129 : 1893 1904.
9. Lee, J. et al. 1996. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts. Int. J. Cancer 67 : 372 378.
10. Schipani, E. et al. 2001. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 15 : 2865 2876.
11. Bunn, H. & R. Poyton. 1996. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76 : 839 885.
12. Liu, L. & M. Simon. 2004. Regulation of transcription and translation by hypoxia. Cancer Biol. Ther. 3 : 492 497.
13. Semenza, G. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 : 721 732.
14. Giaccia, A., B. Siim & R. Johnson. 2003. HIF-1 as a target for drug development. Nat. Rev. Drug. Discov 2 : 803 811.
15. Kaelin, W.G.J. 2002. How oxygen makes its presence felt. Genes Dev. 16 : 1441 1445.
16. Jaakkola, P. et al. 2001. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292 : 468 472.
17. Min, J. et al. 2002. Structure of an HIF-1alpha-pVHL complex: hydroxyproline recognition in signaling. Science 296 : 1886 1889.
18. Chan, D. et al. 2002. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 277 : 40112 40117.
19. Ohh, M. & W.G. Kaelin. 1999. The von Hippel-Lindau tumor suppressor protein: new perspectives. Mol. Med. Today 5 : 257 263.
20. Kallio, P.J. et al. 1998. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J. 17 : 6573 6586.
21. Leo, C., A. Giaccia & N. Denko. 2004. The hypoxic tumor microenvironment and gene expression. Semin. Radiat. Oncol. 14 : 207 214.
22. Bishop, T. et al. 2004. Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans. PLoS. Biol. 2 : e289.
23. Ryan, H.E., J. Lo & R.S. Johnson. 1998. HIF 1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17 : 3005 3015.
24. Iyer, N. et al. 1998a. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1alpha. Genes Dev. 12 : 149 162.
25. Carmeliet, P. et al. 1998. Role of HIF-1alpha in hypoxia mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394 : 485 490.
26. Gnarra, J. et al. 1997. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc. Natl. Acad. Sci. USA 94 : 9102 9107.
27. Pfander, D. et al. 2004. Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development 131 : 2497 2508.
28. Pfander, D. et al. 2003. HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J. Cell. Sci. 116 : 1819 1826.
29. Ferrara, N., H. Gerber & J. LeCouter. 2003. The biology of VEGF and its receptors. Nat. Med. 9 : 669 676.
30. Cramer, T. et al. 2004. Expression of VEGF isoforms by epiphyseal chondrocytes during low-oxygen tension is HIF-1 alpha dependent. Osteoarthritis Cartilage 12 : 433 439.
31. Zelzer, E. et al. 2004. VEGFA is necessary for chondrocyte survival during bone development. Development 131 : 2161 2171.
32. Gerber, H. et al. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5 : 623 628.
33. Maes, C. et al. 2002. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech. Dev. 111 : 61 73.
34. Ivkovic, S., B. Yoon, et al. 2003. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130 : 2779 2791.
35. Zelzer, E. et al. 2001. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech. Dev. 106 : 97 106.
36. Maes, C. et al. 2004. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J. Clin. Invest. 113 : 188 199.
37. Tang, N. et al. 2004. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6 : 485 495.
38. Danial, N. et al. 2003. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424 : 952 956.
39. Biju, M. et al. 2004. Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes. Mol. Cell. Biol. 24 : 9038 9047.
40. Lee, M. et al. 2004. Identification of the hypoxia-inducible factor 1 alpha-responsive HGTD-P gene as a mediator in the mitochondrial apoptotic pathway. Mol. Cell. Biol. 24 : 3918 3927.
41. Bruick, R. 2000. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. USA 97 : 9082 9087.
42. Alarcon, R., N. Denko, A. Giaccia. 2001. Genetic determinants that influence hypoxia-induced apoptosis. Novartis Found. Symp. 240 : 115 128.
43. Denko, N. et al. 2003. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22 : 5907 5914.
44. Goda, N. et al. 2003. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol. Cell. Biol. 23 : 359 369.
45. Kaelin, W. & E. Maher. 1998. The VHL tumor-suppressor gene paradigm. Trends Genet. 14 : 423 426.
46. St-Jacques, B., M. Hammerschmidt & A. McMahon. 1999. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 15 : 2072 2086.